Appili Therapeutics Inc faced a significant downturn in its stock price, raising concerns among investors.
In yesterday's trading session, Appili Therapeutics Inc (APLI.TO) saw its stock price drop by a staggering 33.33%, closing at just CA$0.01. This dramatic decline has left many investors questioning the future of the biopharmaceutical company, which focuses on developing treatments for infectious diseases.
Investor takeaway: Investors should closely monitor Appili's financial health and operational developments, especially after such a sharp decline in stock value.
Advertisement
Appili Therapeutics Inc
APLI.TO
APLI.TO
Appili Therapeutics Inc
WealthAwesomeMarket cap
$661,830
52W high
$0.03
52W low
$0.01
1W change
-50.00%
Beta
-0.19
Analyst Price Targets
Based on analyst covering APLI · as of Sep 17, 2026
Wall Street analysts forecast APLI stock price to rise 2900.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.15
+2900.0% Upside
Current Price
C$0.01
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on APLI's historical volatility
30-Day Vol
473.3%
Annualized
90-Day Vol
313.5%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.00
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.00 | C$0.00 – C$0.02 |
| 60 trading days | C$0.00 | C$0.00 – C$0.04 |
| 90 trading days | C$0.00 | C$0.00 – C$0.07 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Bull case
Despite the recent drop, Appili has reported some encouraging financial results in the past, including significant funding awards that could support its product development.
Bear case
The steep decline in stock price raises concerns about investor confidence. Without new positive developments, the stock may continue to struggle.
Understanding the Decline
Appili Therapeutics Inc's stock plummeted by 33.33% in yesterday's trading session, closing at CA$0.01. This decline is particularly alarming given the company's recent announcements regarding its financial and operational results. Investors may be reacting to a lack of immediate positive news or clarity on the company's strategic direction.
Advertisement
Market Reaction and Investor Sentiment
The sharp drop in Appili's stock price indicates a significant shift in investor sentiment. With a market cap now around CA$1.32 million, concerns about the company's viability and future growth prospects are at the forefront. Investors should consider the implications of this decline and whether it reflects deeper issues within the company.
Looking Ahead
Moving forward, investors will need to keep a close eye on Appili Therapeutics Inc for any new developments or announcements that could impact its stock performance. The recent financial results showed some promise, but without a clear path forward, the stock may continue to face challenges.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
